Literature DB >> 15868051

Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.

Bernadette Catalan-Soares1, Anna Bárbara de F Carneiro-Proietti, Fernando Augusto Proietti.   

Abstract

Brazil may have the highest absolute number of HTLV-I/II seropositive individuals in the world. Screening potential blood donors for HTLV-I/II is mandatory in Brazil. The public blood center network accounts for about 80.0% of all blood collected. We conducted a cross-sectional study to assess the geographic distribution of HTLV-I/II serological screening prevalence rates in blood donors from 27 large urban areas in the various States of Brazil, from 1995 to 2000. Enzyme immunoassay (EIA) was used to test for HTLV-I/II. The mean prevalence rates ranged from 0.4/1,000 in Florianopolis, capital of Santa Catarina State, in the South, to 10.0/1,000 in São Luiz, Maranhão State, in the Northeast. EIA prevalence rates are lower in the South and higher in the North and Northeast. The reasons for such heterogeneity may be multiple and need further studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868051     DOI: 10.1590/s0102-311x2005000300027

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  68 in total

1.  Tax gene characterization of human T-lymphotropic virus type 1 strains from Brazilian HIV-coinfected patients.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Rosangela Rodrigues; Helena Kaminami Morimoto; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-20       Impact factor: 2.205

2.  Prevalence of Human T Cell Leukaemia Virus amongst Blood Donors.

Authors:  C N Chaudhari; T Shah; R N Misra
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Molecular detection of human T cell lymphotropic virus type 1 in pregnant women from Maranhão state, Brazil.

Authors:  Maria de Fátima Castro Mendes; José de Ribamar Oliveira Lima; Bruna de Oliveira de Melo; Conceição de Maria Fernandes da Silva Pinto; Hermerson Sousa Maia; Thiago Azevedo Feitosa Ferro; Silvio Gomes Monteiro; Edel Figueiredo Barbosa Stancioli; Maria Rosa Quaresma Bomfim
Journal:  Braz J Microbiol       Date:  2020-01-28       Impact factor: 2.476

4.  Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease.

Authors:  Paula F Blatyta; Shannon Kelly; Ester Sabino; Liliana Preiss; Franciane Mendes; Anna B Carneiro-Proietti; Daniela de Oliveira Werneck Rodrigues; Rosimere Mota; Paula Loureiro; Claudia Maximo; Miriam Park; Alfredo Mendrone-Jr; Thelma T Gonçalez; Cesar de Almeida Neto; Brian Custer
Journal:  Transfusion       Date:  2019-12-05       Impact factor: 3.157

5.  Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.

Authors:  Mariana Tomazini Pinto; Tathiane Maistro Malta; Evandra Strazza Rodrigues; Daniel Guariz Pinheiro; Rodrigo Alexandre Panepucci; Kelen Cristina Ribeiro Malmegrim de Farias; Alessandra De Paula Sousa; Osvaldo Massaiti Takayanagui; Yuetsu Tanaka; Dimas Tadeu Covas; Simone Kashima
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-16       Impact factor: 2.205

6.  Human T cell lymphotropic virus type 2a strains among HIV type 1-coinfected patients from Brazil have originated mostly from Brazilian Amerindians.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Helena Kaminami Morimoto; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-11       Impact factor: 2.205

7.  Inability to detect human T cell lymphotropic virus type 2-specific antibodies in a patient coinfected with HIV-1, human T cell lymphotropic virus type 1, human T cell lymphotropic virus type 2, and hepatitis C virus.

Authors:  Adele Caterino-de-Araujo; Mariana Cavalheiro Magri; Neuza Satomi Sato; Helena Kaminami Morimoto; Luis Fernando de Macedo Brigido; Arilson Akira Morimoto
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-19       Impact factor: 2.205

8.  Human T lymphotropic virus types 1 and 2: a point of view.

Authors:  Angela Cristina Malheiros Luzo
Journal:  Rev Bras Hematol Hemoter       Date:  2013

9.  Prevalence of human T-cell lymphotropic virus types 1 and 2 in blood donors of the Caruaru Blood Center (Hemope).

Authors:  Waleska Mayara Gomes de Lima; Fabrício Andrade Martins Esteves; Maria do Carmo Morais Rodrigues Torres; Edna Suely Feitosa Pires
Journal:  Rev Bras Hematol Hemoter       Date:  2013

10.  Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.

Authors:  Yun Brenda Chang; Zhanna Kaidarova; Daniel Hindes; Marjorie Bravo; Nancy Kiely; Hany Kamel; Denise Dubay; Barbara Hoose; Edward L Murphy
Journal:  J Infect Dis       Date:  2013-09-24       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.